E. Gabriela Chiorean

机构：University of Washington, Fred Hutch Cancer Center · ORCID：0000-0003-3306-9592

发表论文 400 篇 · 总被引 20839 次 · h-index 53

代表论文

• Abstract LB407: Daraxonrasib plus chemotherapy (CT) as first-line (1L) treatment for patients (Pts) with metastatic pancreatic adenocarcinoma (mPDAC) (2026 · Cancer Research · 被引 5)
• Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Metastatic Pancreatic Ductal Adenocarcinoma: PCRT16-001 (2026 · Cancers · 被引 3)
• ACR Appropriateness Criteria® Screening, Locoregional Assessment, and Surveillance of Pancreatic Ductal Adenocarcinoma: 2025 Update (2025 · Journal of the American College of Radiology · 被引 3)
• Avutometinib/defactinib and gemcitabine/nab-paclitaxel combination in first-line metastatic pancreatic ductal adenocarcinoma: Updated safety and efficacy of a phase 1b/2 study (RAMP 205). (2025 · Journal of Clinical Oncology · 被引 3)
• A new dawn in cancer immunotherapy: the promise of mutant KRAS-specific vaccines (2025 · Translational Gastroenterology and Hepatology · 被引 3)
• Updates on molecular targets and clinical trials with targeted therapies for pancreatic cancer (2025 · Surgical Oncology · 被引 2)